No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
MERC Mercer International
- 8.160
- +0.070+0.87%
Trading Jul 22 11:56 ET
545.49MMarket Cap-2372P/E (TTM)
8.190High8.000Low29.05KVolume8.040Open8.090Pre Close235.00KTurnover0.05%Turnover RatioLossP/E (Static)66.85MShares11.10252wk High0.95P/B440.88MFloat Cap6.89652wk Low0.30Dividend TTM54.03MShs Float16.561Historical High3.68%Div YieldTTM2.35%Amplitude0.178Historical Low8.090Avg Price1Lot Size
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
CIBC Maintains Mercer International(MERC.US) With Hold Rating, Cuts Target Price to $10
CIBC analyst Hamir Patel maintains $Mercer International(MERC.US)$ with a hold rating, and adjusts the target price from $11 to $10.According to TipRanks data, the analyst has a success rate of 55.3%
Express News | Mercer International Inc : CIBC Cuts Target Price to $10 From $11
Mercer International Inc. Receives Improved ESG Risk Rating From Sustainalytics
July 17, 2024 / All Stories, Company News, Featured, Investors Mercer International Inc. receives improved ESG Risk Rating from SustainalyticsNEW YORK, NY, July 17, 2024Mercer International Inc. (
RBC Lowers Price Target on Mercer International to $10 From $11, Maintains Sector Perform Rating
06:40 AM EDT, 07/11/2024 (MT Newswires) -- RBC Lowers Price Target on Mercer International to $10 From $11, Maintains Sector Perform
Express News | Mercer International Inc : RBC Cuts Target Price to $10 From $11
The Majority of US Employers Plan to Maintain Their Current Benefits in 2025, Despite Rising Healthcare Costs, Says Mercer
NEW YORK--(BUSINESS WIRE)--Mercer, a business of Marsh McLennan (NYSE: MMC) and a global leader in redefining the world of work, reshaping retirement and investment outcomes and unlocking real health
Comments
Mercer's acquisition of MDK is a strategic move to bolster its services for ultrahigh-net-worth clients, a rapidly expanding segment. The deal also aims to broaden Mercer's footprint in the Pacific Northwest market.
Mercer Makes Ultrahigh-Net-Worth Play With Acquisition of $2.5 Billion Seattle Firm -- Barrons.comThe fall in revenue and lack of profitability for Mercer International contribute to a pessimistic market viewpoint. However, the company's substantial dividend payments paint a more comprehensive picture, when considering total shareholder return.
Upgrades
• $A.O. Smith(AOS.US$ : Longbow Research Upgrades to Buy from Neutral - PT $71
• $Callon Petroleum(CPE.US$ : RBC Upgrades to Outperform from Sector Perform - PT $75
• $Dun & Bradstreet(DNB.US$ : BofA Securities Upgrades to Neutral from Underperform - PT $17 (from $16)
• $Enanta Pharmaceuticals(ENTA.US$ : Evercore ISI Upgrades to Outperform from In Line - PT $62 (from $39)
• $Corning(GLW.US$ : CFRA Upgrades to Strong Buy ...
• $A.O. Smith(AOS.US$ : Longbow Research Upgrades to Buy from Neutral - PT $71
• $Callon Petroleum(CPE.US$ : RBC Upgrades to Outperform from Sector Perform - PT $75
• $Dun & Bradstreet(DNB.US$ : BofA Securities Upgrades to Neutral from Underperform - PT $17 (from $16)
• $Enanta Pharmaceuticals(ENTA.US$ : Evercore ISI Upgrades to Outperform from In Line - PT $62 (from $39)
• $Corning(GLW.US$ : CFRA Upgrades to Strong Buy ...
8
$Mercer International(MERC.US$ The head of India's leading medical research institute said on Wednesday that Mercer's new oral crown drug molnupiravir has "significant safety issues" that may prevent it from joining the country's list of viral treatments.
The oral drug, molnupiravir, is said to ultimately stop the replication of the virus by introducing a different mechanism in the genetic material, but it could affect growing human cells.
The oral drug, molnupiravir, is said to ultimately stop the replication of the virus by introducing a different mechanism in the genetic material, but it could affect growing human cells.
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg